DOI: 10.1016/s1359-6446(00)01545-2. Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)

Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)

10.1016/s1359-6446(00)01545-2

Crossref journal-article

Elsevier BV

Drug Discovery Today (78)

Bibliography

Miller, W. H., Keenan, R. M., Willette, R. N., & Lark, M. W. (2000). Identification and in vivo efficacy of small-molecule antagonists of integrin Î±vÎ²3 (the vitronectin receptor). Drug Discovery Today, 5(9), 397â408.

Authors 4

William H Miller (first)
Richard M Keenan (additional)
Robert N Willette (additional)
Michael W Lark (additional)

References 70 Referenced 90

10.1016/S1357-2725(99)00043-6 / Int. J. Biochem. Cell Biol. / Bi-directional signal transduction by integrin receptors by Coppolino (2000)
10.1016/S0165-6147(99)01410-8 / Trends in Pharm. Sci. / Integrin cell adhesion receptors and the concept of agonism by Humphries (2000)
10.1517/14728222.4.2.143 / Emerg. Ther. Targets / Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications by Mousa (2000)
10.1007/s000180050443 / Cell. Mol. Life Sci. / Integrin antagonists by Curley (1999)
10.1517/13543776.9.9.1237 / Exp. Opin. Ther. Patents / Anti-integrins as a potential therapeutic target in angiogenesis by Mousa (1999)
10.1172/JCI6869 / J. Clin. Invest. / The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development by Eliceiri (1999)
{'key': '10.1016/S1359-6446(00)01545-2_BIB7', 'first-page': '23', 'article-title': 'Integrins and angiogenesis', 'volume': '28', 'author': 'Riddelle-Spencer', 'year': '1999', 'journal-title': 'Ernst Schering Res. Found. Workshop'} / Ernst Schering Res. Found. Workshop / Integrins and angiogenesis by Riddelle-Spencer (1999)
{'key': '10.1016/S1359-6446(00)01545-2_BIB8', 'series-title': 'Cell Adhesion Molecules and Matrix Proteins: Role in Health and Diseases', 'first-page': '85', 'article-title': 'Integrin αvβ3: a therapeutic target for vascular remodelling', 'author': 'Stadel', 'year': '1998'} / Cell Adhesion Molecules and Matrix Proteins: Role in Health and Diseases / Integrin αvβ3: a therapeutic target for vascular remodelling by Stadel (1998)
10.2174/138161280306221010111710 / Current Pharmaceutical Design / Vascular indications for integrin αv antagonists by Samanen (1997)
10.1016/S1357-2725(96)00155-0 / Int. J. Biochem. Cell Biol. / The αvβ3 integrin ‘vitronectin receptor’ by Horton (1997)
{'key': '10.1016/S1359-6446(00)01545-2_BIB11', 'series-title': 'Principles of Bone Biology', 'first-page': '217', 'article-title': 'Cell surface attachment molecules in bone', 'author': 'Horton', 'year': '1996'} / Principles of Bone Biology / Cell surface attachment molecules in bone by Horton (1996)
10.1016/0092-8674(92)90115-S / Cell / Integrins: versatility, modulation, and signaling in cell adhesion by Hynes (1992)
10.1152/ajplung.2000.278.1.L217 / Am. J. Physiol. Lung Cell. Mol. Physiol. / Vascular expression of the αvβ3-integrin in lung and other organs by Singh (2000)
10.1517/13543776.6.11.1175 / Exp. Opin. Ther. Patents / Glycoprotein IIb/IIIa antagonists by Wityak (1996)
10.1016/S0065-7743(08)60449-2 / Ann. Rep. Med. Chem. / GPIIb/IIIa antagonists by Samanen (1996)
10.1016/S0021-9258(17)31981-6 / J. Biol. Chem. / Selective recognition of cyclic RGD peptides of NMR defined conformation by αIIbβ3, αvβ3, and α5β1 integrins by Pfaff (1994)
10.1021/ja953163+ / J. Amer. Chem. Soc. / Type II′ to Type I β-turn swap changes specificity for integrins by Bach (1996)
10.1021/jm960276a / J. Med. Chem. / Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the αvβ3 receptor by Burgess (1996)
10.1021/jm970205r / J. Med. Chem. / Discovery of potent nonpeptide vitro-nectin receptor (αvβ3) antagonists by Keenan (1997)
10.1021/jm960558a / J. Med. Chem. / Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists by Samanen (1996)
{'issue': 'Suppl. I', 'key': '10.1016/S1359-6446(00)01545-2_BIB21', 'first-page': 'S289', 'article-title': 'A high affinity non-peptide αvβ3 ligand inhibits osteoclast activity in vitro and in vivo', 'volume': '11', 'author': 'Rodan', 'year': '1996', 'journal-title': 'J. Bone Min. Res.'} / J. Bone Min. Res. / A high affinity non-peptide αvβ3 ligand inhibits osteoclast activity in vitro and in vivo by Rodan (1996)
10.1016/S0960-894X(99)00661-7 / Bioorg. Med. Chem. Lett. / RGD mimetics containing a central hydantoin scaffold: αvβ3 vs αIIbβ3 selectivity requirements by Peyman (2000)
10.1016/S0960-894X(99)00114-6 / Bioorg. Med. Chem. Lett. / Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of αvβ3 antagonists lead compounds by Rockwell (1999)
10.1021/jm9900321 / J. Med. Chem. / Isoxazolines as potent antagonists of the integrin αvβ3 by Pitts (2000)
10.2174/092986730610220401161259 / Curr. Med. Chem. / Structure-activity relationships of β-amino acid-containing integrin antagonists by Scarborough (1999)
10.1016/S0960-894X(97)00200-X / Bioorg. Med. Chem. Lett. / Solid-phase synthesis of a selective αvβ3 integrin antagonist library by Corbett (1997)
10.2174/0929867305666220314204036 / Curr. Med. Chem. / Combinatorial chemistry techniques applied to nonpeptide integrin antagonists by Hoekstra (1998)
10.1021/jm990049j / J. Med. Chem. / Disubstituted indazoles as potent antagonists of the integrin αvβ3 by Batt (2000)
10.1097/00005344-199904000-00018 / J. Cardiovasc. Pharm. / αvβ3 integrin binding affinity and specificity of SM256 in various species by Mousa (1999)
10.1053/hj.1999.v138.99078 / Am. Heart J. / Potential non-glycoprotein IIb/IIIa effects of abciximab by Coller (1999)
10.1055/s-0037-1615850 / Thromb. Haemostasis / Binding of abciximab to αvβ3 and activated αMβ2 receptors. With a review of platelet-leukocyte interactions by Coller (1999)
10.1016/S0968-0896(98)00090-X / Bioorg. Med. Chem. / Design, synthesis and biological evaluation of nonpeptide integrin antagonists by Nicolaou (1998)
10.1002/(SICI)1521-3765(20000218)6:4<666::AID-CHEM666>3.0.CO;2-Z / Chem. Eur. J. / Synthesis and biological evaluation of integrin antagonists containing trans- and cis-disubstituted THF rings by Osterkamp (2000)
10.1016/S0960-894X(98)00555-1 / Bioorg. Med. Chem. Lett. / Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists by Keenan (1998)
10.1016/S0960-894X(98)00556-3 / Bioorg. Med. Chem. Lett. / Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model by Keenan (1998)
10.1016/S0960-894X(99)00282-6 / Bioorg. Med. Chem. Lett. / Nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics by Keenan (1999)
10.1016/S0960-894X(99)00283-8 / Bioorg. Med. Chem. Lett. / Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model by Miller (1999)
{'key': '10.1016/S1359-6446(00)01545-2_BIB38', 'first-page': '1232', 'article-title': 'Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist', 'volume': '27', 'author': 'Ward', 'year': '1999', 'journal-title': 'Drug Metab. Dispos.'} / Drug Metab. Dispos. / Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist by Ward (1999)
10.1021/jm990446u / J. Med. Chem. / Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic by Miller (2000)
10.1016/S0040-4020(97)90389-6 / Tetrahedron / Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV by Nicolaou (1997)
10.1016/S0040-4020(99)00599-2 / Tetrahedron / Synthesis and biological evaluation of dianhydrohexitol integrin antagonists by Osterkamp (1999)
10.1016/S0960-894X(98)00433-8 / Bioorg. Med. Chem. Lett. / Construction of a family of biphenyl combinatorial libraries: structure-activity studies utilizing libraries of mixtures by Neustadt (1998)
10.1016/S1874-5113(99)80011-2 / Adv. Amino Acid Mim. Pep. / Sugar amino acids and carbohydrates as scaffolds and peptidomimetics by Lohof (1999)
10.1021/jo9906173 / J. Org. Chem. / Novel solid-phase synthesis of azapeptides and azapeptoids via Fmoc-strategy and its application in the synthesis of RGD-mimetics by Gibson (1999)
10.1016/S0040-4039(99)01915-2 / Tetrahedron Lett. / Liquid phase parallel synthesis of iminodiacetic acid derivatives by Cheng (1999)
10.1021/jm980344o / J. Med. Chem. / Emerging therapies for the prevention or treatment of postmenopausal osteoporosis by Sato (1999)
10.1242/jcs.112.22.3985 / J. Cell Sci. / Role of αvβ3 integrin in osteoclast migration and formation of the sealing zone by Nakamura (1999)
10.1210/en.137.3.918 / Endocrinology / Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat by Crippes (1996)
10.1210/en.139.3.1411 / Endocrinology / The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats by Yamamoto (1998)
10.1172/JCI119404 / J. Clin. Invest. / A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo by Engleman (1997)
{'key': '10.1016/S1359-6446(00)01545-2_BIB51', 'first-page': '612', 'article-title': 'Design and characterization of an orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist, SB 265123, for the prevention of bone loss in osteoporosis', 'volume': '291', 'author': 'Lark', 'year': '1999', 'journal-title': 'J. Pharm. Exp. Ther.'} / J. Pharm. Exp. Ther. / Design and characterization of an orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist, SB 265123, for the prevention of bone loss in osteoporosis by Lark (1999)
Lark, M.W. et al. Antagonism of the osteoclast vitronectin receptor with an orally active non-peptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Min. Res. (in press).
{'key': '10.1016/S1359-6446(00)01545-2_BIB53', 'first-page': '1930', 'article-title': 'A peptidomimetic antagonist of the integrin αvβ3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy', 'volume': '58', 'author': 'Carron', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / A peptidomimetic antagonist of the integrin αvβ3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy by Carron (1998)
{'key': '10.1016/S1359-6446(00)01545-2_BIB54', 'first-page': '959', 'article-title': 'Novel small molecule αv integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors', 'volume': '19', 'author': 'Kerr', 'year': '1999', 'journal-title': 'Anticancer Res.'} / Anticancer Res. / Novel small molecule αv integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors by Kerr (1999)
10.1016/0140-6736(93)92628-7 / Lancet / Clinical management of rheumatoid arthritis by Brooks (1993)
10.1172/JCI3756 / J. Clin. Invest. / Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist by Storgard (1999)
10.1590/S0100-879X1999000500011 / Braz. J. Med. Biol. Res. / A role for angiogenesis in rheumatoid arthritis by Stupack (1999)
{'key': '10.1016/S1359-6446(00)01545-2_BIB58', 'first-page': 'S118', 'article-title': 'Effect of SB273005, an orally active, non-peptide αvβ3 vitronectin receptor (VNR) antagonist in the adjuvant arthritic (AA) rat', 'volume': '42', 'author': 'Badger', 'year': '1999', 'journal-title': 'Arthritis and Rheum.'} / Arthritis and Rheum. / Effect of SB273005, an orally active, non-peptide αvβ3 vitronectin receptor (VNR) antagonist in the adjuvant arthritic (AA) rat by Badger (1999)
10.1002/(SICI)1097-4644(19991201)75:3<492::AID-JCB13>3.0.CO;2-Z / J. Cell. Biochem. / αvβ3, αvβ5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation by Corjay (1999)
10.1016/S0741-5214(94)70127-X / J. Vasc. Surg. / Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA by Choi (1994)
10.1016/S0008-6363(97)00184-3 / Cardiovasc. Res. / Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin αvβ3 and osteopontin expression during neointima formation by Srivatsa (1997)
10.1161/01.RES.84.11.1268 / Circ. Res. / Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (αvβ3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits by Coleman (1999)
10.3109/15419069809109146 / Cell Adhes. Commun. / Reduced intimal thickening following αvβ3 blockade is associated with smooth muscle cell apoptosis by van der Zee (1998)
10.1161/01.RES.85.11.1040 / Circ. Res. / Reduction in atherosclerotic lesion size in pigs by αvβ3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signalling by Nichols (1999)
10.1210/en.140.10.4616 / Endocrinology / Synthetic αvβ3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication by Clemmons (1999)
{'issue': 'Suppl. I', 'key': '10.1016/S1359-6446(00)01545-2_BIB66', 'first-page': 'I', 'article-title': 'A selective integrin αvβ3 antagonist reduces neointimal proliferation in a porcine coronary angioplasty model via a thrombus independent mechanism', 'volume': '100', 'author': 'Chico', 'year': '1999', 'journal-title': 'Circulation'} / Circulation / A selective integrin αvβ3 antagonist reduces neointimal proliferation in a porcine coronary angioplasty model via a thrombus independent mechanism by Chico (1999)
10.1002/(SICI)1097-4644(20000501)77:2<213::AID-JCB5>3.0.CO;2-T / J. Cell. Biochem. / Inhibition of neointima formation by a nonpeptide αvβ3 integrin receptor antagonist in a rabbit cuff model by Racanelli (2000)
{'issue': 'Suppl. I', 'key': '10.1016/S1359-6446(00)01545-2_BIB68', 'first-page': 'I', 'article-title': 'Vitronectin (αvβ3) receptor blockade reduces restenosis and intramural macrophage infiltration following balloon angioplasty of the atherosclerotic rabbit femoral artery', 'volume': '100', 'author': 'Bishop', 'year': '1999', 'journal-title': 'Circulation'} / Circulation / Vitronectin (αvβ3) receptor blockade reduces restenosis and intramural macrophage infiltration following balloon angioplasty of the atherosclerotic rabbit femoral artery by Bishop (1999)
10.1253/jcj.61.893 / Jpn. Circ. J. / Arterial wall neovascularization – potential role in atherosclerosis and restenosis by Pels (1997)
10.1016/S0955-0674(97)80124-X / Curr. Opin. Cell Biol. / Integrins and anoikis by Frisch (1997)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 10:19 a.m.)
Deposited	2 years, 4 months ago (April 9, 2023, 1:54 a.m.)
Indexed	1 year ago (Aug. 7, 2024, 3:53 p.m.)
Issued	24 years, 11 months ago (Sept. 1, 2000)
Published	24 years, 11 months ago (Sept. 1, 2000)
Published Print	24 years, 11 months ago (Sept. 1, 2000)

Funders 0

None

BibTeX

@article{Miller_2000, title={Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)}, volume={5}, ISSN={1359-6446}, url={http://dx.doi.org/10.1016/s1359-6446(00)01545-2}, DOI={10.1016/s1359-6446(00)01545-2}, number={9}, journal={Drug Discovery Today}, publisher={Elsevier BV}, author={Miller, William H and Keenan, Richard M and Willette, Robert N and Lark, Michael W}, year={2000}, month=sep, pages={397–408} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        8,
        7
      ]
    ],
    "date-time": "2024-08-07T19:53:42Z",
    "timestamp": 1723060422667
  },
  "reference-count": 70,
  "publisher": "Elsevier BV",
  "issue": "9",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2000,
            9,
            1
          ]
        ],
        "date-time": "2000-09-01T00:00:00Z",
        "timestamp": 967766400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2000,
        9
      ]
    ]
  },
  "DOI": "10.1016/s1359-6446(00)01545-2",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T14:19:09Z",
    "timestamp": 1027606749000
  },
  "page": "397-408",
  "source": "Crossref",
  "is-referenced-by-count": 90,
  "title": "Identification and in vivo efficacy of small-molecule antagonists of integrin \u03b1v\u03b23 (the vitronectin receptor)",
  "prefix": "10.1016",
  "volume": "5",
  "author": [
    {
      "given": "William H",
      "family": "Miller",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Richard M",
      "family": "Keenan",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Robert N",
      "family": "Willette",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Michael W",
      "family": "Lark",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "DOI": "10.1016/S1357-2725(99)00043-6",
      "article-title": "Bi-directional signal transduction by integrin receptors",
      "volume": "32",
      "author": "Coppolino",
      "year": "2000",
      "journal-title": "Int. J. Biochem. Cell Biol."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "DOI": "10.1016/S0165-6147(99)01410-8",
      "article-title": "Integrin cell adhesion receptors and the concept of agonism",
      "volume": "21",
      "author": "Humphries",
      "year": "2000",
      "journal-title": "Trends in Pharm. Sci."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "DOI": "10.1517/14728222.4.2.143",
      "article-title": "Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications",
      "volume": "4",
      "author": "Mousa",
      "year": "2000",
      "journal-title": "Emerg. Ther. Targets"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "DOI": "10.1007/s000180050443",
      "article-title": "Integrin antagonists",
      "volume": "56",
      "author": "Curley",
      "year": "1999",
      "journal-title": "Cell. Mol. Life Sci."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "1237",
      "DOI": "10.1517/13543776.9.9.1237",
      "article-title": "Anti-integrins as a potential therapeutic target in angiogenesis",
      "volume": "9",
      "author": "Mousa",
      "year": "1999",
      "journal-title": "Exp. Opin. Ther. Patents"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "1227",
      "DOI": "10.1172/JCI6869",
      "article-title": "The role of \u03b1v integrins during angiogenesis: insights into potential mechanisms of action and clinical development",
      "volume": "103",
      "author": "Eliceiri",
      "year": "1999",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB7",
      "first-page": "23",
      "article-title": "Integrins and angiogenesis",
      "volume": "28",
      "author": "Riddelle-Spencer",
      "year": "1999",
      "journal-title": "Ernst Schering Res. Found. Workshop"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB8",
      "series-title": "Cell Adhesion Molecules and Matrix Proteins: Role in Health and Diseases",
      "first-page": "85",
      "article-title": "Integrin \u03b1v\u03b23: a therapeutic target for vascular remodelling",
      "author": "Stadel",
      "year": "1998"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "DOI": "10.2174/138161280306221010111710",
      "article-title": "Vascular indications for integrin \u03b1v antagonists",
      "volume": "3",
      "author": "Samanen",
      "year": "1997",
      "journal-title": "Current Pharmaceutical Design"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "DOI": "10.1016/S1357-2725(96)00155-0",
      "article-title": "The \u03b1v\u03b23 integrin \u2018vitronectin receptor\u2019",
      "volume": "29",
      "author": "Horton",
      "year": "1997",
      "journal-title": "Int. J. Biochem. Cell Biol."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB11",
      "series-title": "Principles of Bone Biology",
      "first-page": "217",
      "article-title": "Cell surface attachment molecules in bone",
      "author": "Horton",
      "year": "1996"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1016/0092-8674(92)90115-S",
      "article-title": "Integrins: versatility, modulation, and signaling in cell adhesion",
      "volume": "69",
      "author": "Hynes",
      "year": "1992",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "L217",
      "DOI": "10.1152/ajplung.2000.278.1.L217",
      "article-title": "Vascular expression of the \u03b1v\u03b23-integrin in lung and other organs",
      "volume": "278",
      "author": "Singh",
      "year": "2000",
      "journal-title": "Am. J. Physiol. Lung Cell. Mol. Physiol."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "1175",
      "DOI": "10.1517/13543776.6.11.1175",
      "article-title": "Glycoprotein IIb/IIIa antagonists",
      "volume": "6",
      "author": "Wityak",
      "year": "1996",
      "journal-title": "Exp. Opin. Ther. Patents"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "DOI": "10.1016/S0065-7743(08)60449-2",
      "article-title": "GPIIb/IIIa antagonists",
      "volume": "31",
      "author": "Samanen",
      "year": "1996",
      "journal-title": "Ann. Rep. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "20233",
      "DOI": "10.1016/S0021-9258(17)31981-6",
      "article-title": "Selective recognition of cyclic RGD peptides of NMR defined conformation by \u03b1IIb\u03b23, \u03b1v\u03b23, and \u03b15\u03b21 integrins",
      "volume": "269",
      "author": "Pfaff",
      "year": "1994",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "293",
      "DOI": "10.1021/ja953163+",
      "article-title": "Type II\u2032 to Type I \u03b2-turn swap changes specificity for integrins",
      "volume": "118",
      "author": "Bach",
      "year": "1996",
      "journal-title": "J. Amer. Chem. Soc."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "4520",
      "DOI": "10.1021/jm960276a",
      "article-title": "Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the \u03b1v\u03b23 receptor",
      "volume": "39",
      "author": "Burgess",
      "year": "1996",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "2289",
      "DOI": "10.1021/jm970205r",
      "article-title": "Discovery of potent nonpeptide vitro-nectin receptor (\u03b1v\u03b23) antagonists",
      "volume": "40",
      "author": "Keenan",
      "year": "1997",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "4867",
      "DOI": "10.1021/jm960558a",
      "article-title": "Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists",
      "volume": "39",
      "author": "Samanen",
      "year": "1996",
      "journal-title": "J. Med. Chem."
    },
    {
      "issue": "Suppl. I",
      "key": "10.1016/S1359-6446(00)01545-2_BIB21",
      "first-page": "S289",
      "article-title": "A high affinity non-peptide \u03b1v\u03b23 ligand inhibits osteoclast activity in vitro and in vivo",
      "volume": "11",
      "author": "Rodan",
      "year": "1996",
      "journal-title": "J. Bone Min. Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "DOI": "10.1016/S0960-894X(99)00661-7",
      "article-title": "RGD mimetics containing a central hydantoin scaffold: \u03b1v\u03b23 vs \u03b1IIb\u03b23 selectivity requirements",
      "volume": "10",
      "author": "Peyman",
      "year": "2000",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "937",
      "DOI": "10.1016/S0960-894X(99)00114-6",
      "article-title": "Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of \u03b1v\u03b23 antagonists lead compounds",
      "volume": "9",
      "author": "Rockwell",
      "year": "1999",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "27",
      "DOI": "10.1021/jm9900321",
      "article-title": "Isoxazolines as potent antagonists of the integrin \u03b1v\u03b23",
      "volume": "43",
      "author": "Pitts",
      "year": "2000",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "971",
      "DOI": "10.2174/092986730610220401161259",
      "article-title": "Structure-activity relationships of \u03b2-amino acid-containing integrin antagonists",
      "volume": "6",
      "author": "Scarborough",
      "year": "1999",
      "journal-title": "Curr. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "1371",
      "DOI": "10.1016/S0960-894X(97)00200-X",
      "article-title": "Solid-phase synthesis of a selective \u03b1v\u03b23 integrin antagonist library",
      "volume": "7",
      "author": "Corbett",
      "year": "1997",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.2174/0929867305666220314204036",
      "article-title": "Combinatorial chemistry techniques applied to nonpeptide integrin antagonists",
      "volume": "5",
      "author": "Hoekstra",
      "year": "1998",
      "journal-title": "Curr. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "DOI": "10.1021/jm990049j",
      "article-title": "Disubstituted indazoles as potent antagonists of the integrin \u03b1v\u03b23",
      "volume": "43",
      "author": "Batt",
      "year": "2000",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "641",
      "DOI": "10.1097/00005344-199904000-00018",
      "article-title": "\u03b1v\u03b23 integrin binding affinity and specificity of SM256 in various species",
      "volume": "33",
      "author": "Mousa",
      "year": "1999",
      "journal-title": "J. Cardiovasc. Pharm."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "S1",
      "DOI": "10.1053/hj.1999.v138.99078",
      "article-title": "Potential non-glycoprotein IIb/IIIa effects of abciximab",
      "volume": "138",
      "author": "Coller",
      "year": "1999",
      "journal-title": "Am. Heart J."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "326",
      "DOI": "10.1055/s-0037-1615850",
      "article-title": "Binding of abciximab to \u03b1v\u03b23 and activated \u03b1M\u03b22 receptors. With a review of platelet-leukocyte interactions",
      "volume": "82",
      "author": "Coller",
      "year": "1999",
      "journal-title": "Thromb. Haemostasis"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "1185",
      "DOI": "10.1016/S0968-0896(98)00090-X",
      "article-title": "Design, synthesis and biological evaluation of nonpeptide integrin antagonists",
      "volume": "6",
      "author": "Nicolaou",
      "year": "1998",
      "journal-title": "Bioorg. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "666",
      "DOI": "10.1002/(SICI)1521-3765(20000218)6:4<666::AID-CHEM666>3.0.CO;2-Z",
      "article-title": "Synthesis and biological evaluation of integrin antagonists containing trans- and cis-disubstituted THF rings",
      "volume": "6",
      "author": "Osterkamp",
      "year": "2000",
      "journal-title": "Chem. Eur. J."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "3165",
      "DOI": "10.1016/S0960-894X(98)00555-1",
      "article-title": "Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (\u03b1v\u03b23) antagonists",
      "volume": "8",
      "author": "Keenan",
      "year": "1998",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "3171",
      "DOI": "10.1016/S0960-894X(98)00556-3",
      "article-title": "Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (\u03b1v\u03b23) antagonist with efficacy in a restenosis model",
      "volume": "8",
      "author": "Keenan",
      "year": "1998",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "1801",
      "DOI": "10.1016/S0960-894X(99)00282-6",
      "article-title": "Nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics",
      "volume": "9",
      "author": "Keenan",
      "year": "1999",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "1807",
      "DOI": "10.1016/S0960-894X(99)00283-8",
      "article-title": "Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model",
      "volume": "9",
      "author": "Miller",
      "year": "1999",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB38",
      "first-page": "1232",
      "article-title": "Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist",
      "volume": "27",
      "author": "Ward",
      "year": "1999",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB39",
      "doi-asserted-by": "crossref",
      "first-page": "22",
      "DOI": "10.1021/jm990446u",
      "article-title": "Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic",
      "volume": "43",
      "author": "Miller",
      "year": "2000",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "8751",
      "DOI": "10.1016/S0040-4020(97)90389-6",
      "article-title": "Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV",
      "volume": "53",
      "author": "Nicolaou",
      "year": "1997",
      "journal-title": "Tetrahedron"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB41",
      "doi-asserted-by": "crossref",
      "first-page": "10713",
      "DOI": "10.1016/S0040-4020(99)00599-2",
      "article-title": "Synthesis and biological evaluation of dianhydrohexitol integrin antagonists",
      "volume": "55",
      "author": "Osterkamp",
      "year": "1999",
      "journal-title": "Tetrahedron"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB42",
      "doi-asserted-by": "crossref",
      "first-page": "2395",
      "DOI": "10.1016/S0960-894X(98)00433-8",
      "article-title": "Construction of a family of biphenyl combinatorial libraries: structure-activity studies utilizing libraries of mixtures",
      "volume": "8",
      "author": "Neustadt",
      "year": "1998",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "263",
      "DOI": "10.1016/S1874-5113(99)80011-2",
      "article-title": "Sugar amino acids and carbohydrates as scaffolds and peptidomimetics",
      "volume": "2",
      "author": "Lohof",
      "year": "1999",
      "journal-title": "Adv. Amino Acid Mim. Pep."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB44",
      "doi-asserted-by": "crossref",
      "first-page": "7388",
      "DOI": "10.1021/jo9906173",
      "article-title": "Novel solid-phase synthesis of azapeptides and azapeptoids via Fmoc-strategy and its application in the synthesis of RGD-mimetics",
      "volume": "64",
      "author": "Gibson",
      "year": "1999",
      "journal-title": "J. Org. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "8975",
      "DOI": "10.1016/S0040-4039(99)01915-2",
      "article-title": "Liquid phase parallel synthesis of iminodiacetic acid derivatives",
      "volume": "40",
      "author": "Cheng",
      "year": "1999",
      "journal-title": "Tetrahedron Lett."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB46",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1021/jm980344o",
      "article-title": "Emerging therapies for the prevention or treatment of postmenopausal osteoporosis",
      "volume": "42",
      "author": "Sato",
      "year": "1999",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB47",
      "doi-asserted-by": "crossref",
      "first-page": "3985",
      "DOI": "10.1242/jcs.112.22.3985",
      "article-title": "Role of \u03b1v\u03b23 integrin in osteoclast migration and formation of the sealing zone",
      "volume": "112",
      "author": "Nakamura",
      "year": "1999",
      "journal-title": "J. Cell Sci."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "918",
      "DOI": "10.1210/en.137.3.918",
      "article-title": "Antibody to \u03b23 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat",
      "volume": "137",
      "author": "Crippes",
      "year": "1996",
      "journal-title": "Endocrinology"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB49",
      "doi-asserted-by": "crossref",
      "first-page": "1411",
      "DOI": "10.1210/en.139.3.1411",
      "article-title": "The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats",
      "volume": "139",
      "author": "Yamamoto",
      "year": "1998",
      "journal-title": "Endocrinology"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB50",
      "doi-asserted-by": "crossref",
      "first-page": "2284",
      "DOI": "10.1172/JCI119404",
      "article-title": "A peptidomimetic antagonist of the \u03b1v\u03b23 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo",
      "volume": "99",
      "author": "Engleman",
      "year": "1997",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB51",
      "first-page": "612",
      "article-title": "Design and characterization of an orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist, SB 265123, for the prevention of bone loss in osteoporosis",
      "volume": "291",
      "author": "Lark",
      "year": "1999",
      "journal-title": "J. Pharm. Exp. Ther."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB52",
      "unstructured": "Lark, M.W. et al. Antagonism of the osteoclast vitronectin receptor with an orally active non-peptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Min. Res. (in press)."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB53",
      "first-page": "1930",
      "article-title": "A peptidomimetic antagonist of the integrin \u03b1v\u03b23 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy",
      "volume": "58",
      "author": "Carron",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB54",
      "first-page": "959",
      "article-title": "Novel small molecule \u03b1v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors",
      "volume": "19",
      "author": "Kerr",
      "year": "1999",
      "journal-title": "Anticancer Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB55",
      "doi-asserted-by": "crossref",
      "first-page": "286",
      "DOI": "10.1016/0140-6736(93)92628-7",
      "article-title": "Clinical management of rheumatoid arthritis",
      "volume": "341",
      "author": "Brooks",
      "year": "1993",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB56",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "DOI": "10.1172/JCI3756",
      "article-title": "Decreased angiogenesis and arthritic disease in rabbits treated with an \u03b1v\u03b23 antagonist",
      "volume": "103",
      "author": "Storgard",
      "year": "1999",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB57",
      "doi-asserted-by": "crossref",
      "first-page": "573",
      "DOI": "10.1590/S0100-879X1999000500011",
      "article-title": "A role for angiogenesis in rheumatoid arthritis",
      "volume": "32",
      "author": "Stupack",
      "year": "1999",
      "journal-title": "Braz. J. Med. Biol. Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB58",
      "first-page": "S118",
      "article-title": "Effect of SB273005, an orally active, non-peptide \u03b1v\u03b23 vitronectin receptor (VNR) antagonist in the adjuvant arthritic (AA) rat",
      "volume": "42",
      "author": "Badger",
      "year": "1999",
      "journal-title": "Arthritis and Rheum."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB59",
      "doi-asserted-by": "crossref",
      "first-page": "492",
      "DOI": "10.1002/(SICI)1097-4644(19991201)75:3<492::AID-JCB13>3.0.CO;2-Z",
      "article-title": "\u03b1v\u03b23, \u03b1v\u03b25, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation",
      "volume": "75",
      "author": "Corjay",
      "year": "1999",
      "journal-title": "J. Cell. Biochem."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB60",
      "doi-asserted-by": "crossref",
      "first-page": "125",
      "DOI": "10.1016/S0741-5214(94)70127-X",
      "article-title": "Inhibition of neointimal hyperplasia by blocking \u03b1v\u03b23 integrin with a small peptide antagonist GpenGRGDSPCA",
      "volume": "19",
      "author": "Choi",
      "year": "1994",
      "journal-title": "J. Vasc. Surg."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB61",
      "doi-asserted-by": "crossref",
      "first-page": "408",
      "DOI": "10.1016/S0008-6363(97)00184-3",
      "article-title": "Selective \u03b1v\u03b23 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin \u03b1v\u03b23 and osteopontin expression during neointima formation",
      "volume": "36",
      "author": "Srivatsa",
      "year": "1997",
      "journal-title": "Cardiovasc. Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB62",
      "doi-asserted-by": "crossref",
      "first-page": "1268",
      "DOI": "10.1161/01.RES.84.11.1268",
      "article-title": "Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (\u03b1v\u03b23), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits",
      "volume": "84",
      "author": "Coleman",
      "year": "1999",
      "journal-title": "Circ. Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB63",
      "doi-asserted-by": "crossref",
      "first-page": "371",
      "DOI": "10.3109/15419069809109146",
      "article-title": "Reduced intimal thickening following \u03b1v\u03b23 blockade is associated with smooth muscle cell apoptosis",
      "volume": "6",
      "author": "van der Zee",
      "year": "1998",
      "journal-title": "Cell Adhes. Commun."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB64",
      "doi-asserted-by": "crossref",
      "first-page": "1040",
      "DOI": "10.1161/01.RES.85.11.1040",
      "article-title": "Reduction in atherosclerotic lesion size in pigs by \u03b1v\u03b23 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signalling",
      "volume": "85",
      "author": "Nichols",
      "year": "1999",
      "journal-title": "Circ. Res."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB65",
      "doi-asserted-by": "crossref",
      "first-page": "4616",
      "DOI": "10.1210/en.140.10.4616",
      "article-title": "Synthetic \u03b1v\u03b23 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication",
      "volume": "140",
      "author": "Clemmons",
      "year": "1999",
      "journal-title": "Endocrinology"
    },
    {
      "issue": "Suppl. I",
      "key": "10.1016/S1359-6446(00)01545-2_BIB66",
      "first-page": "I",
      "article-title": "A selective integrin \u03b1v\u03b23 antagonist reduces neointimal proliferation in a porcine coronary angioplasty model via a thrombus independent mechanism",
      "volume": "100",
      "author": "Chico",
      "year": "1999",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB67",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "DOI": "10.1002/(SICI)1097-4644(20000501)77:2<213::AID-JCB5>3.0.CO;2-T",
      "article-title": "Inhibition of neointima formation by a nonpeptide \u03b1v\u03b23 integrin receptor antagonist in a rabbit cuff model",
      "volume": "77",
      "author": "Racanelli",
      "year": "2000",
      "journal-title": "J. Cell. Biochem."
    },
    {
      "issue": "Suppl. I",
      "key": "10.1016/S1359-6446(00)01545-2_BIB68",
      "first-page": "I",
      "article-title": "Vitronectin (\u03b1v\u03b23) receptor blockade reduces restenosis and intramural macrophage infiltration following balloon angioplasty of the atherosclerotic rabbit femoral artery",
      "volume": "100",
      "author": "Bishop",
      "year": "1999",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB69",
      "doi-asserted-by": "crossref",
      "first-page": "893",
      "DOI": "10.1253/jcj.61.893",
      "article-title": "Arterial wall neovascularization \u2013 potential role in atherosclerosis and restenosis",
      "volume": "61",
      "author": "Pels",
      "year": "1997",
      "journal-title": "Jpn. Circ. J."
    },
    {
      "key": "10.1016/S1359-6446(00)01545-2_BIB70",
      "doi-asserted-by": "crossref",
      "first-page": "701",
      "DOI": "10.1016/S0955-0674(97)80124-X",
      "article-title": "Integrins and anoikis",
      "volume": "9",
      "author": "Frisch",
      "year": "1997",
      "journal-title": "Curr. Opin. Cell Biol."
    }
  ],
  "container-title": "Drug Discovery Today",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1359644600015452?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1359644600015452?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        9
      ]
    ],
    "date-time": "2023-04-09T05:54:11Z",
    "timestamp": 1681019651000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1359644600015452"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2000,
        9
      ]
    ]
  },
  "references-count": 70,
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2000,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "S1359644600015452"
  ],
  "URL": "http://dx.doi.org/10.1016/S1359-6446(00)01545-2",
  "relation": {},
  "ISSN": [
    "1359-6446"
  ],
  "subject": [],
  "container-title-short": "Drug Discovery Today",
  "published": {
    "date-parts": [
      [
        2000,
        9
      ]
    ]
  }
}